Literature DB >> 21917786

Functional duality of astrocytes in myelination.

Besma Nash1, Christine E Thomson, Christopher Linington, Ariel T Arthur, John D McClure, Martin W McBride, Susan C Barnett.   

Abstract

Astrocytes undergo major phenotypic changes in response to injury and disease that directly influence repair in the CNS, but the mechanisms involved are poorly understood. Previously, we have shown that neurosphere-derived rat astrocytes plated on poly-L-lysine (PLL-astrocytes) support myelination in dissociated rat spinal cord cultures (myelinating cultures). It is hypothesized that astrocyte reactivity can affect myelination, so we have exploited this culture system to ascertain how two distinct astrocyte phenotypes influence myelination. Astrocytes plated on tenascin C (TnC-astrocytes), a method to induce quiescence, resulted in less myelinated fibers in the myelinating cultures when compared with PLL-astrocytes. In contrast, treatment of myelinating cultures plated on PLL-astrocytes with ciliary neurotrophic factor (CNTF), a cytokine known to induce an activated astrocyte phenotype, promoted myelination. CNTF could also reverse the effect of quiescent astrocytes on myelination. A combination of microarray gene expression analysis and quantitative real-time PCR identified CXCL10 as a potential candidate for the reduction in myelination in cultures on TnC-astrocytes. The effect of TnC-astrocytes on myelination was eliminated by neutralizing CXCL10 antibodies. Conversely, CXCL10 protein inhibited myelination on PLL-astrocytes. Furthermore, CXCL10 treatment of purified oligodendrocyte precursor cells did not affect proliferation, differentiation, or process extension compared with untreated controls, suggesting a role in glial/axonal ensheathment. These data demonstrate a direct correlation of astrocyte phenotypes with their ability to support myelination. This observation has important implications with respect to the development of therapeutic strategies to promote CNS remyelination in demyelinating diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21917786      PMCID: PMC6623277          DOI: 10.1523/JNEUROSCI.1449-11.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  68 in total

1.  The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar.

Authors:  R J McKeon; M J Jurynec; C R Buck
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

2.  Primer3 on the WWW for general users and for biologist programmers.

Authors:  S Rozen; H Skaletsky
Journal:  Methods Mol Biol       Date:  2000

3.  CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis.

Authors:  B T Fife; K J Kennedy; M C Paniagua; N W Lukacs; S L Kunkel; A D Luster; W J Karpus
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

Review 4.  Cellular aspects of trophic actions in the nervous system.

Authors:  D M Weisenhorn; J Roback; A N Young; B H Wainer
Journal:  Int Rev Cytol       Date:  1999

5.  Generation of oligodendroglial progenitors from neural stem cells.

Authors:  S C Zhang; C Lundberg; D Lipsitz; L T O'Connor; I D Duncan
Journal:  J Neurocytol       Date:  1998

6.  CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions.

Authors:  K E Balashov; J B Rottman; H L Weiner; W W Hancock
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

Review 7.  The ciliary neurotrophic factor and its receptor, CNTFR alpha.

Authors:  M W Sleeman; K D Anderson; P D Lambert; G D Yancopoulos; S J Wiegand
Journal:  Pharm Acta Helv       Date:  2000-03

8.  Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients.

Authors:  T L Sørensen; M Tani; J Jensen; V Pierce; C Lucchinetti; V A Folcik; S Qin; J Rottman; F Sellebjerg; R M Strieter; J L Frederiksen; R M Ransohoff
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

9.  CNTF and CNTF receptor alpha are constitutively expressed by astrocytes in the mouse brain.

Authors:  Christine Dallner; Alisa G Woods; Thomas Deller; Matthias Kirsch; Hans-Dieter Hofmann
Journal:  Glia       Date:  2002-03-15       Impact factor: 7.452

10.  Identification of growth factors that promote long-term proliferation of olfactory ensheathing cells and modulate their antigenic phenotype.

Authors:  Claire L Alexander; Una F Fitzgerald; Susan C Barnett
Journal:  Glia       Date:  2002-03-15       Impact factor: 7.452

View more
  60 in total

1.  Plasticity of the myelination genomic fabric.

Authors:  Sanda Iacobas; Neil M Thomas; Dumitru A Iacobas
Journal:  Mol Genet Genomics       Date:  2012-01-13       Impact factor: 3.291

Review 2.  Innate immunity in the central nervous system.

Authors:  Richard M Ransohoff; Melissa A Brown
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

Review 3.  Modulators of microglial activation and polarization after intracerebral haemorrhage.

Authors:  Xi Lan; Xiaoning Han; Qian Li; Qing-Wu Yang; Jian Wang
Journal:  Nat Rev Neurol       Date:  2017-05-19       Impact factor: 42.937

4.  Extracellular matrix composition determines astrocyte responses to mechanical and inflammatory stimuli.

Authors:  Kasey M Johnson; Richard Milner; Stephen J Crocker
Journal:  Neurosci Lett       Date:  2015-06-09       Impact factor: 3.046

5.  Differentiation of oligodendrocytes from mouse induced pluripotent stem cells without serum.

Authors:  Sachiyo Misumi; Ruriko Nishigaki; Yoshitomo Ueda; Yoko Watanabe; Yuko Shimizu; Akimasa Ishida; ChaGyun Jung; Hideki Hida
Journal:  Transl Stroke Res       Date:  2013-01-11       Impact factor: 6.829

6.  Employing an open-source tool to assess astrocyte tridimensional structure.

Authors:  Gabriela Tavares; Manuella Martins; Joana Sofia Correia; Vanessa Morais Sardinha; Sónia Guerra-Gomes; Sofia Pereira das Neves; Fernanda Marques; Nuno Sousa; João Filipe Oliveira
Journal:  Brain Struct Funct       Date:  2016-09-30       Impact factor: 3.270

7.  The fornix provides multiple biomarkers to characterize circuit disruption in a mouse model of Alzheimer's disease.

Authors:  Alexandra Badea; Lauren Kane; Robert J Anderson; Yi Qi; Mark Foster; Gary P Cofer; Neil Medvitz; Anne F Buckley; Andreas K Badea; William C Wetsel; Carol A Colton
Journal:  Neuroimage       Date:  2016-08-10       Impact factor: 6.556

8.  A rapid and reproducible assay for modeling myelination by oligodendrocytes using engineered nanofibers.

Authors:  Seonok Lee; S Y Christin Chong; Samuel J Tuck; Joseph M Corey; Jonah R Chan
Journal:  Nat Protoc       Date:  2013-04       Impact factor: 13.491

Review 9.  The evolving role of neuro-immune interaction in brain repair after cerebral ischemic stroke.

Authors:  Xin Wang; Wei Xuan; Zi-Yu Zhu; Yan Li; Hao Zhu; Ling Zhu; Dan-Yun Fu; Li-Qun Yang; Pei-Ying Li; Wei-Feng Yu
Journal:  CNS Neurosci Ther       Date:  2018-10-22       Impact factor: 5.243

Review 10.  Early to Long-Term Alterations of CNS Barriers After Traumatic Brain Injury: Considerations for Drug Development.

Authors:  Beatriz Rodriguez-Grande; Aleksandra Ichkova; Sighild Lemarchant; Jerome Badaut
Journal:  AAPS J       Date:  2017-09-13       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.